DalsnaFinance Account

Bioage Labs Inc $BIOA

Health Care

Russell 2000 California

Create a scorecard

$5.53

+0.02 (+0.36%)

As of Oct 22, 2026, 9:31 PM EDT

Price history

Loading chart…

Bioage Labs Inc (BIOA) is trading up at $5.53 (+0.36%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: September 26, 2024 · $18.00 offering · NASDAQ · View IPO details →

Bioage Labs Inc revenue & net income history (FY2023–FY2025)

RevenueNet incomeNet margin (right axis, %)

Bioage Labs Inc annual financial statements
	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	—	$0	$8.99M
Operating income	−$48.4M	−$78.2M	−$92.8M
Operating margin	—	—	−1031.5%
Net income	−$63.9M	−$71.1M	−$80.6M
Net margin	—	—	−896.1%
EPS (diluted)	−$38.17	−$6.63	−$2.24
Balance sheet
Cash and equivalents	$21.6M	$354.3M	$188.9M
Total assets	$25.9M	$358.2M	$294.9M
Total liabilities	$66.6M	$35.1M	$22.8M
Long-term debt	$8.20M	$2.50M	$0
Shareholders' equity	−$173.4M	$323.1M	$272.1M
Cash flow
Operating cash flow	−$37.4M	−$51.5M	−$81.6M
Capital expenditure	$166.0K	$366.0K	$719.0K
Free cash flow	−$37.5M	−$51.9M	−$82.3M

RevenueNet incomeNet margin (right axis, %)

Bioage Labs Inc quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$0	—	$1.45M	$2.41M	$2.05M	$3.08M	$2.77M	$2.45M
Growth (year over year)	—	—	—	—	—	—	+91.0%	+1.6%
Operating income	−$24.8M	—	−$16.4M	−$24.8M	−$23.1M	−$28.4M	−$25.4M	−$29.3M
Operating margin	—	—	−1133.4%	−1027.0%	−1126.6%	−923.4%	−915.4%	−1196.8%
Net income	−$23.4M	—	−$12.9M	−$21.6M	−$20.2M	−$25.9M	−$22.3M	−$26.1M
Net margin	—	—	−891.0%	−894.0%	−982.0%	−842.9%	−802.8%	−1064.7%
EPS (diluted)	−$6.70	—	−$0.36	−$0.60	−$0.56	−$0.72	−$0.52	−$0.58
Balance sheet
Cash and equivalents	$334.5M	$354.3M	$257.5M	$220.3M	$215.6M	$188.9M	$241.8M	$74.0M
Total assets	$337.4M	$358.2M	$343.8M	$322.1M	$305.1M	$294.9M	$397.7M	$396.9M
Total liabilities	$23.6M	$35.1M	$30.7M	$27.4M	$27.6M	$22.8M	$18.5M	$22.0M
Long-term debt	$3.94M	$2.50M	$1.06M	$0	$0	$0	—	—
Shareholders' equity	$313.7M	$323.1M	$313.2M	$294.8M	$277.5M	$272.1M	$379.1M	$374.9M
Cash flow
Operating cash flow	−$14.9M	—	−$17.4M	−$20.0M	−$16.0M	−$28.3M	−$24.0M	−$19.3M
Capital expenditure	$305.0K	—	$426.0K	$159.0K	$22.0K	$112.0K	$26.0K	$328.0K
Free cash flow	−$15.2M	—	−$17.8M	−$20.1M	−$16.1M	−$28.4M	−$24.1M	−$19.6M

From Bioage Labs Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →